Citations 1225

Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia

Brain | November 5, 2017 | Volume: 141 | Issue: 1 | Pages: 271-287

10.1093/brain/awx320 | PMID 29228201

Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases

Alzheimer's & Dementia | October 31, 2017 | Volume: 14 | Issue: 3 | Pages: 352-366

10.1016/j.jalz.2017.09.012 | PMID 29107053

Abstract Introduction Comparative transcriptome analyses in Alzheimer's disease (AD) and other neurodegenerative proteinopathies can uncover both shared and distinct disease pathways. Methods We analyzed 940 brain transcriptomes including patients with AD, progressive supranuclear palsy (PSP; a primary tauopathy), and control subjects. Results We identified transcriptional coexpression networks implicated in myelination, which were lower in PSP temporal cortex (TCX) compared with AD. Some of these associations were retained even after adjustments for brain cell population changes. These TCX myelination network structures were preserved in cerebellum but they were not differentially expressed in cerebellum between AD and PSP. Myelination networks were downregulated in both AD and PSP, when compared with control TCX samples. Discussion Downregulation of myelination networks may underlie both PSP and AD pathophysiology, but may be more pronounced in PSP. These data also highlight conservation of transcriptional networks across brain regions and the influence of cell type changes on these networks.
Prevalence and Natural History of Superficial Siderosis

Stroke | October 26, 2017 | Volume: 48 | Issue: 12 | Pages: 3210-3214

10.1161/strokeaha.117.018974 | PMID 29070715

Background and Purpose— Superficial siderosis (SS) is characterized by hemosiderin deposition in the superficial layers of the central nervous system and can be seen during postmortem examination or with iron-sensitive magnetic resonance imaging techniques. The distribution of SS may predict the probable underlying cause. This study aimed to report the prevalence and natural history of SS in a population-based study. Methods— Brain magnetic resonance imaging scans from the MCSA (Mayo Clinic Study of Aging), a population-based study of residents 50 to 89 years of age in Olmsted County, Minnesota, were reviewed. Participants with imaging consistent with SS were identified from 2011 through 2016. An inverse probability weighting approach was used to convert our observed frequencies to population prevalence of SS. Additional data abstracted included amyloid positron emission tomography, Apolipoprotein E genotype, coexisting cerebral microbleeds, and extent of SS. Results— A total of 1412 participants had eligible magnetic resonance imaging scans. Two participants had infratentorial SS, restricted to the posterior fossa. Thirteen participants had cortical SS involving the cerebral convexities (7 focal and 6 disseminated). Only 3 of the participants with cortical SS (23%) also had cerebral microbleeds. The population prevalence of SS was 0.21% (95% confidence interval, 0–0.45) in those 50 to 69 years old and 1.43% (confidence interval, 0.53–2.34) in those over 69 years old. Apolipoprotein E ε2 allele was more common in those with SS (57.1% versus 15.0%; P <0.001). Compared with participants without SS, those with SS were also more likely to have a positive amyloid positron emission tomographic scan (76.9% versus 29.8%; P <0.001). Conclusions— SS may be encountered in the general elderly population. The association with increased amyloid burden and Apolipoprotein E ε2 genotype supports cerebral amyloid angiopathy as the most common mechanism. Longitudinal follow-up is needed to evaluate the risk of subsequent hemorrhage in cases of incidentally discovered SS.
[P1–334]: CHARACTERIZATION OF THE CLINICAL AND NEUROIMAGING FEATURES OF PATIENTS WITH DEMENTIA WITH LEWY BODIES ASSOCIATED WITH VARIANTS IN GLUCOCEREBROSIDASE (GBA)

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2017.06.350

[P4–179]: ASPECTS OF SUBJECTIVE COGNITIVE DECLINE THAT PREDICT INCIDENT MCI IN THE MAYO CLINC STUDY OF AGING

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_28 | Pages: No page available

10.1016/j.jalz.2017.06.2046

[P1–473]: DOES PERFORMANCE ON COGSTATE VARY LONGITUDINALLY ACROSS DIFFERENT MODES OF ADMINISTRATION?

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_9 | Pages: No page available

10.1016/j.jalz.2017.06.489

[IC‐P‐075]: PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG‐PET IN DEMENTIA WITH LEWY BODIES

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2017.06.2348

[O1–06–05]: SUBJECT‐LEVEL ASSESSMENT OF REGIONAL CORRELATIONS BETWEEN TAU‐PET, AMYLOID‐PET, MRI AND FDG‐PET ACROSS THE CLINICAL SPECTRUM OF ALZHEIMER's DISEASE

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2017.07.068

[IC‐P‐019]: EFFECTS OF USING A NOVEL LONGITUDINAL PROCESSING PIPELINE FOR MEASURING CHANGE OVER TIME IN PIB‐PET

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2017.06.2291

[P2–415]: THE MAYO CLINIC ADULT LIFESPAN TEMPLATE: BETTER QUANTIFICATION ACROSS THE LIFESPAN

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_16 | Pages: No page available

10.1016/j.jalz.2017.06.1071